The FDA’s rule change requires that all women in the US be informed about breast density and options for supplemental screening.
Articles on Breast cancer screening guidelines
Displaying all articles
Dense breast tissue is common and normal, but it can make cancer more difficult to detect. FDA requirements going into effect in September 2024 will dictate that patients be better informed about it.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Guidelines galore suggest how we can take care of ourselves in concert with our doctors. Here’s why it’s not as easy as it may seem (and how those guidelines get written)
Top contributors
-
Associate Professor, Neurology, University of Florida
-
Professor of Radiology, School of Medicine, University of Pittsburgh
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Professor of Medicine, Bond University
-
Senior Lecturer, School of Medicine, Griffith University
-
Professor of Public Health, University of Sydney
-
Associate Professor, Biostatistician, Institute for Evidence-Based Healthcare, Bond University
-
Associate Director of Cancer Care Equity, Yale Cancer Center, Yale University
-
Professor of Radiology, Boston University
-
Emeritus Professor of Medicine, Boston University
-
Assistant Professor of Health Policy and Clinical Practice, Dartmouth College